Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
48.87
-1.06 (-2.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CRISPR Therapeutics AG - Common Shares
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
35
36
Next >
Flee to Healthcare Stocks if Recession Rears its Head?
September 20, 2023
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.
Via
MarketBeat
Topics
Economy
Where Will CRISPR Therapeutics Be in 5 Years?
↗
September 19, 2023
The company hasn't performed well in the past five years, but things could change.
Via
The Motley Fool
1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know
↗
September 19, 2023
Good medicines aren't always good business.
Via
The Motley Fool
2 Top Trends to Invest $500 In Right Now
↗
September 18, 2023
Early investors in these trends may reap the rewards over time.
Via
The Motley Fool
Looking for Growth? These Companies' Revenue May Skyrocket
↗
September 17, 2023
Catalysts on the horizon could drive gains in these top stocks.
Via
The Motley Fool
2 No-Brainer Biotech Stocks to Buy Right Now
↗
September 12, 2023
You can get in early on these potential winners.
Via
The Motley Fool
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
↗
September 16, 2023
The returns are impressive, but will they continue to be so?
Via
The Motley Fool
Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics
↗
September 15, 2023
They're both liable to grow by a lot, but one of them is a safer bet in the near term.
Via
The Motley Fool
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
↗
September 15, 2023
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.
Via
Investor's Business Daily
3 Top Healthcare Stocks Defying the Bear Market
↗
September 15, 2023
Revenue at all three companies improved last quarter, and their share prices have followed suit.
Via
The Motley Fool
Better Bull Market Buy: CRISPR vs. Medtronic Stock
↗
September 14, 2023
Investors may look for growth stocks ahead of the next bull market.
Via
The Motley Fool
3 Biotech Blockbusters to Turn $5,000 Into $50,000
↗
September 12, 2023
These transformative early-stage biotech stocks can deliver triple-digit upside if their key milestones are achieved on time.
Via
InvestorPlace
More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics
↗
September 12, 2023
These companies are innovators, something that can prove highly lucrative.
Via
The Motley Fool
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
↗
September 07, 2023
With CRISPR Therapeutics announcing the departure of its co-founder, investors are also walking for the exits on CRSP stock.
Via
InvestorPlace
2 Brilliant Growth Stocks With Upsides of About 70%, According to Wall Street
↗
September 06, 2023
Wall Street analysts foresee these pre-commercial-stage drugmakers rocketing higher over the next 12 months.
Via
The Motley Fool
With a Prediction for a 70% Gain, Is Wall Street Too Optimistic About This Biotech Stock?
↗
September 05, 2023
Big news could come in December and in March.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy Now: September 2023
↗
September 04, 2023
With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize.
Via
InvestorPlace
2 Spectacular Growth Stocks You Can Buy in September With No Hesitation
↗
September 03, 2023
There's no need for any anxiety with investing in these great stocks.
Via
The Motley Fool
3 Beaten-Down Biotech Stocks Bound for a Bounce Back
↗
September 02, 2023
Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs.
Via
InvestorPlace
Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again
↗
August 30, 2023
The famous growth investor has been making some interesting stock moves lately.
Via
The Motley Fool
3 Surprisingly Underrated Stocks to Buy Right Now
↗
August 26, 2023
These stocks deserve more respect than they're getting.
Via
The Motley Fool
Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge
↗
August 24, 2023
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks
↗
August 24, 2023
The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases.
Via
The Motley Fool
3 Clever Tricks to Find Winning Biotech Stocks
↗
August 24, 2023
You'll need to dig into company details, but the effort is worthwhile.
Via
The Motley Fool
Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M
↗
August 22, 2023
Via
Benzinga
Topics
Earnings
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
↗
August 22, 2023
Helping save and improve patients' lives in novel ways can be a lucrative activity.
Via
The Motley Fool
Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead
↗
August 21, 2023
Via
Benzinga
Stocks to Watch This Week’s Top 7 Wall Street Upgrades
↗
August 21, 2023
With the market printing some red ink recently, investors may take greater confidence in the top Wall Street upgrades this week.
Via
InvestorPlace
Gene Therapy Breakthroughs On The Horizon
↗
August 21, 2023
Vertex Pharmaceuticals and CRISPR Therapeutics, alongside bluebird bio, are penning a new chapter in the story of gene therapy for sickle cell disease.
Via
Talk Markets
3 Green Flags for Biotech Stocks in 2023 and Beyond
↗
August 19, 2023
The industry is changing rapidly, and for the better.
Via
The Motley Fool
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
